Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines by Castle,  J. C. et al.
Expression of 24,426 human alternative splicing events
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Alternative pre–messenger RNA splicing influences development, physiology and disease, but its regulation in humans is not well
understood, partially because of the limited scale at which the expression of specific splicing events has been measured. We
generated the first genome-scale expression compendium of human alternative splicing events using custom whole-transcript
microarrays monitoring expression of 24,426 alternative splicing events in 48 diverse human samples. Over 11,700 genes and
9,500 splicing events were differentially expressed, providing a rich resource for studying splicing regulation. An unbiased,
systematic screen of 21,760 4-mer to 7-mer words for cis-regulatory motifs identified 143 RNA ’words’ enriched near regulated
cassette exons, including six clusters of motifs represented by UCUCU, UGCAUG, UGCU, UGUGU, UUUU and AGGG, which
map to trans-acting regulators PTB, Fox, Muscleblind, CELF/CUG-BP, TIA-1 and hnRNP F/H, respectively. Each cluster showed a
distinct pattern of genomic location and tissue specificity. For example, UCUCU occurs 110 to 35 nucleotides preceding cassette
exons upregulated in brain and striated muscle but depleted in other tissues. UCUCU and UGCAUG seem to have similar
function but independent action, occurring 5¢ and 3¢, respectively, of 33% of the cassette exons upregulated in skeletal muscle
but co-occurring for only 2%.
Alternative splicing is a key mechanism for generating proteomic
diversity, and as many as 74% of human multi-exon genes are
alternatively spliced1. Many recent studies point to the importance
of detection and measurement of alternative splicing. For example,
more genetic variations in the CEU HapMap population manifest
themselves through changes in transcript structure, including
splicing, than changes in gene transcription2. However, our know-
ledge of the differential expression of specific splicing events and
characterization of corresponding cis-regulatory elements is
limited. Likewise, although sequence targets of several individual
RNA-binding splicing factors have been characterized, much remains
to be learned about their regulatory mechanism within different
human tissues.
PTB proteins are known to interact with pyrimidine-rich elements,
such as UCUCU3–5; the FOX proteins bind UGCAUG6,7; hnRNP
A/B and hnRNP F/H bind GGGG and AGGGG, respectively, and
GGG8,9; muscleblind (MBNL) proteins bind UGCU10; TIA-1 binds U-
rich sequences11; and the CELF proteins12 and SUP-12 (RBM38)12,13
interact with UGUGU. Using microarrays14 and immunoprecipitation
of cross-linked RNA15, a previous study elucidated the binding
element and regulatory influence of neuronal Nova RNA-binding
proteins, showing that Nova binds either YCAY or YCATY (Y,
pyrimidine), and causes exon inclusion or exclusion depending on
the location of the motif relative to the exon.
Assessing the ratios of expression for two mutually exclusive splice
forms (‘splicing-event profiling’) requires probes targeting both exons
and junctions, for example, probes monitoring both the cassette exon
and the junction across the excluded exon. Pan et al.16 (3,100 cassette
exons, 10 tissues), Fagnani et al.17 (3,700 cassette exons, 27 tissues)
and Sugnet et al.18 (6,700 events, 22 tissues) have previously used such
arrays to profile mouse tissues. To further our understanding of
alternative splicing expression and regulation, we generated the first
human genome-wide alternative splicing–event compendium, mon-
itoring 24,426 events in 48 tissues and cell lines, and undertook an
unbiased, systematic search to identify and describe putative regula-
tory motifs.
RESULTS
Microarrays for whole-transcript profiling
We designed microarrays monitoring 203,672 exons and 178,351
exon–exon junctions in 17,939 human genes. These microarrays
report expression of both splicing event isoforms from 8,000 cassette
exons, 3,950 alternative 5¢ splice sites, 3,672 alternative 3¢ splice sites,
3,770 multiple cassette exons, 3,123 mutually exclusive exons and
1,890 inserted introns. The ‘whole transcript’ design used here is
different from exon arrays19, junction arrays1 and cassette exon–
splicing arrays16 in that it includes a constellation of probes targeting
every exon and every junction, similar to the approach of Griffith
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et al.20 (Fig. 1a). Although exon arrays provide an unbiased survey of
transcript structure, they do not monitor connections between indi-
vidual exons or many alternative 5¢ and 3¢ splice sites. Because they
lack junction probes, they also generally monitor only one form of an
alternative splicing event. The inability to monitor both of the two
mutually exclusive forms prevents accurate measurement of expres-
sion ratios of the two forms. Cassette exon splicing arrays, with probes
designed to monitor the inclusion and exclusion of known cassette
exons, are an economical option for profiling cassette exon splicing
events but lack probes to profile other types of alternative splicing (for
example, alternative 5¢ and 3¢ splice sites), do not monitor alternative
5¢ and 3¢ exons, and do not permit discovery of new alternative
splice forms.
Compendium of human alternative splicing events
A set of 48 human tissues and cell lines with dissimilar expression
patterns was hybridized to the arrays, and 11,700 of 18,000
genes monitored by the array showed greater than threefold
change in gene expression relative to the
pool (P o 0.01) in at least one tissue
(Methods and Supplementary Fig. 1 on-
line). Across the 48 tissue panel, 9,516
alternative splicing events were also signifi-
cantly differentially expressed in at least one
tissue (Methods and Supplementary Fig. 2
online), similar to the number of differen-
tially expressed genes.
As an example of the data available for
each gene, results for A2BP1 (Fox-1) are
shown in Figure 1. A2BP1 regulates alterna-
tive splicing and is itself alternatively spliced,
containing alternative 5¢ exons, a pair of
mutually exclusive exons, a cassette exon
and an alternative 3¢ splice site6,21 (Fig. 1a).
A2BP1 is upregulated in muscle and brain
(Fig. 1b). The four alternative 5¢ exons of
transcript NM_018723 were detected in
brain, and the 5¢ exon found in transcript
NM_145893 was detected in muscle. Within
the coding region, brain cells preferentially
include the mutually exclusive exon found in
NM_018723, whereas skeletal muscle cells
include the NM_145893 form. Across all
tissues, A2BP1 gene expression is highest in
heart, skeletal muscle and the nervous system
(Fig. 1c). The first (5¢) mutually exclusive
exon is expressed in nervous-system tissues
while the second (3¢) mutually exclusive exon
is found in heart and skeletal muscle. Expres-
sion of the gene, the first mutually exclusive
exon and the second mutually exclusive exon
can be combined to estimate the relative
abundance of each form across the tissue
panel (Fig. 1c, right; Methods). Of the two
forms represented by the mutually exclusive
exons, brain has a higher proportion of
form NM_018723.
9,516 splice events are differentially
expressed
Across the 48 tissue compendium, 9,516
alternative splicing events were significantly differentially expressed
in at least one tissue (Methods and Supplementary Fig. 2), similar to
the total number of differentially expressed genes (11,700). Of the
monitored cassette exons, 42% were differentially expressed in at least
one tissue (Fig. 2a); a much lower fraction (26%) of monitored
alternative 3¢ splice sites and a higher proportion (55%) of monitored
inserted introns were also differentially expressed. The samples with
the highest number of differentially expressed alternative splicing
events (Fig. 2b) relative to the pool include the cell lines HeLa and
HCT116, peripheral leukocytes, fetal brain, testis, mammary gland,
and skeletal muscle, whereas the samples with the fewest include
adipose, adrenal gland and fetal lung. These rankings parallel those for
gene expression; that is, the same samples types were among those
with the most and fewest differentially expressed genes.
Cassette exon inclusion and exclusion rates varied among the
samples (Fig. 2c). The ratio between the number of cassette exons
differentially included to the number excluded was highest for SW480,
breast and lung tumor, retina and brain samples excluding medulla
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Figure 1 Interrogation of A2BP1 (Fox-1) isoforms on the alternative splicing microarrays. (a) The 19
exons in the locus, including alternative 5¢ exons (green), mutually exclusive exons (blue), a cassette
exon (gray), and an alternative 3¢ splice site (red). Exon (red) and exon–exon junction (green) probes are
shown for several splice-related microarrays. (b) Expression (log10 change relative to reference pool) of
exons (red dots) and junctions (green crosses) in transcripts NM_018723 and NM_145893 in skeletal
muscle (cyan line) and brain (red line). (c) Expression of the gene, exon 15, exon 14 and the combined
splice-event expression level. Red shading represents microarray intensity values; dark pink shading
(right) represents more significant P values. Error bars for log10 ratios represent expression uncertainties
(Methods). Samples are ordered alphabetically as in Figure 2.
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oblongata. To test whether this result might be due to the composition
of the reference pool (normal adult tissues), we re-ratioed to each
individual sample and to the average of all 48 samples, generating 49
in silico reference pools (Methods), and computed inclusion rates,
exclusion rates and ratios. Although the number of cassette exons
included or excluded depended on the reference sample, the inclusion-
to-exclusion rankings of samples were similar regardless of the pool,
with retina and certain brain, tumor and cell lines consistently ranking
highest. These results agree with previous findings that brain tissues
express the greatest number of tissue-specific exons19.
To provide an estimate of the accuracy of the quantitative predic-
tions made by the splicing arrays and analysis tools as part of a larger
study (T.A.C., unpublished data), we tested a sample of 23 predictions
by semiquantitative RT-PCR and found that 74% of the splice
events called differentially expressed by the microarray at P value
o0.1 show changes by PCR of at least 15% in differential expression,
and correlations between the microarray and RT-PCR splice
event proportionalities of r ¼ 0.88 (Methods and Supplementary
Table 1 online).
Transcription and alternative splicing act
independently
Similar to previous results16, we did not
detect significant overlap between the differ-
entially expressed genes and the genes with
differentially expressed splicing events
(P ¼ 0.4) in a given tissue. As one specific
example, CLK1 and CLK2 contain cassette
exons whose exclusion generates a protein
that dimerizes but inhibits kinase activity22.
Here CLK1 and CLK2 showed uncorrelated
gene expression (r ¼ 0.13) across the 48
samples but significantly correlated splicing
expression (r ¼ 0.69) (Fig. 3).
Gene expression correlations are often used
to define ‘edges’ of co-expression networks
and infer functional associations. Here gene–
gene edges determined from correlated gene
expression (r 4 0.75) and those determined
from correlated splice event expression show
only 2% overlap (Supplementary Note
online). Although this overlap is statistically
significant, the small overlap demonstrates
these are largely different regulatory networks.
Finally, we observed that splicing-event
expression and gene expression clustered sam-
ples similarly but with a few exceptions, such
as in lung and breast tumor samples. These
cluster with parental tissues (lung and breast)
using gene expression but with cell lines using
splicing expression, demonstrating that gene
expression in these tumor samples is more
similar to their normal parental tissues
whereas splicing expression is more similar
to cell lines (Supplementary Note).
Expression of specific splicing events
Ten alternative splicing profiles are high-
lighted in the Supplementary Note, including
several associated with nervous system tissues
(GSK3B, MAPT (Tau), APP and CACNA1B),
muscle tissues (MEF2C, CAMK2D, TPM1 and
TPM2), splicing (NOVA1) and cancer (FGFR2).
The human gene CD44 encodes ten variable exons, one of which,
CD44v6, is the target of bivatuzumab mertansine, an antibody for
individuals with advanced carcinoma23 that was discontinued because
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of skin toxicity in phase I trials24. Although in our data CD44v6 is
upregulated in tumors and cancer cell lines, it is expressed highest in
skin, highlighting the potential value of this compendium as a public
resource. Most microarray experiments use a probe or probe set near
the 3¢ end of each gene and consequently would not detect the
isoform-specific variation of CD44.
De novo identification of 143 splicing regulatory elements
We next sought to identify regulatory elements in sequences in and
adjacent to the tissue-regulated cassette exons. We extracted nucleotide
sequence in eight regions (‘neighborhoods’) around regulated exons
and searched for over- and underrepresented nucleotide ‘words’
between 4 and 7 nucleotides in size, using neighborhood-specific
sequences adjacent to all monitored cassette
exons as a background set (Fig. 4a, Methods).
Examined neighborhoods were 200 nucleo-
tides in size for intronic regions and 39
nucleotides for exonic regions, and the
hypergeometric distribution was used to
calculate word-enrichment P values. In
total, 33.5 million enrichment P values
were calculated.
Using a single tissue (skeletal muscle) to
highlight the results, we observed that 8 of
1,024 pentamers have a Bonferroni-corrected
P value o0.01 for enrichment in the
200-nucleotide intronic region upstream of
cassette exons that are upregulated in skeletal
muscle (Fig. 4a). UCUCU is the most
enriched, followed by other pyrimidine
motifs. In the 200-nucleotide intronic region
following cassette exons, three of the 4,096
hexamers are significant. Of note, UGCAUG
is most enriched, followed by GCAUGU and
UGUGUG. No words were significantly
enriched or depleted in the intronic region
preceding the downstream 3¢ splice site.
The compendium can also be used to
find enrichment of specific motifs across
all 48 tissues and cell lines. For example,
the motif UCUCU, which has been
associated with PTB3–5, is enriched in the
intronic region preceding upregulated cassette
exons in brain (P value o1026 in cerebel-
lum), spinal cord, retina, heart and
skeletal muscle (Fig. 4b,c). In this dataset,
PTBP1 gene expression shows a marked
anticorrelation with UCUCU enrichment,
corroborating the inhibitory role of PTBP1.
The UGCAUG motif, associated with the
genes encoding Fox proteins A2BP1 and
RBM9 (ref. 6), is enriched in the intronic
region following upregulated cassette exons
in skeletal muscle (P value o1016) and
heart, with limited enrichment in other
tissues, including brain, adipose and colon.
A2BP1 expression correlates highly
with UGCAUG enrichment, corroborating
the splicing enhancer role of A2BP1. Finally,
although we showed above that muscular
and neuronal tissues express different A2BP1
isoforms, we observed UGCAUG enrichment in both tissues,
although it was highest in muscle and heart.
The systematic analysis of all words in all samples and in all
neighborhoods identified 143 significant motifs (P o 1  10–3,
Bonferroni-corrected; Methods). Two prominent motifs exist
upstream of cassette exons (Fig. 5). A UC-rich cluster, exemplified
by UCUCU, is most enriched in brain and muscle tissues, and the AG-
rich cluster, including GAGG, AGAGG and AGGG, is depleted in
cassette exons upregulated in brain. Other clusters are enriched in
brain (UGCU) and in several tissues (UGCAUG). Smaller clusters
include motifs AGAA, CGCCU and UGAA.
Motifs in the intronic neighborhood following upregulated cassette
exons cluster into five groups (Fig. 6). UGUGUG is enriched in
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Figure 4 Motif identification and enrichment. (a) Identification of alternative splicing motifs enriched in
eight regions adjacent cassette exons upregulated in skeletal muscle. exon5 (exon3), 5¢ (3¢) portion of
cassette exons; uif (dif), intronic fraction upstream (downstream); uexon3 (dexon5) and udif (duif) are
the corresponding regions adjacent the upstream (downstream) exons. Sorted pentamer and hexamer
enrichment in three exemplary regions are shown. Green points are –log10 P values; magenta points are
those with a Bonferroni-corrected P value less than 0.01. Positive (negative) P values indicate motif
enrichment (depletion). The black line represents the average of 200 randomized runs. (b) Enrichment
of UCUCU in human tissues and cell lines. Left axis: enrichment of UCUCU in the 200 nt upstream of
upregulated cassette exons. Right axis: gene expression of PTBP1. (c) Enrichment of UGCAUG. Left
axis: enrichment of UGCAUG in the 200 nt downstream of upregulated cassette exons. Right axis:
gene expression of Fox proteins A2BP1 and RBM9. P values shown are not Bonferroni corrected.
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muscle and brain subsections, UGCAUG is enriched primarily in heart
and skeletal muscle and UUUU is enriched in brain tissues. AG-rich
motifs are depleted downstream of cassette exons upregulated in
several tissues, including brain, peripheral leukocytes, bone marrow
and striated muscle. UACUA is enriched in hypothalamus.
Enrichment occurs in only two other neighborhood and regulation
combinations. Immediately upstream of downregulated cassette
exons, UCUCU enrichment occurs in all samples except brain, spinal
cord, muscle, heart and leukocytes. Coupled with PTBP1 gene
expression, these data corroborate the role of PTB in silencing
downstream exons. In the intron downstream of the exon preceding
upregulated cassette exons (the 5¢ splice site), AU-rich motif enrich-
ment occurs in brain and G-rich motif enrichment occurs in HeLa
and HCT116, whereas G-rich motif depletion occurs in brain. G-rich
motifs are highly enriched at the 5¢ splice site preceding cassette exons
relative to constitutive exons. G-rich motifs may act to silence cassette
exons in brain when positioned in the 5¢ splice site following a cassette
exon and may be a generic 5¢ splice-site defining factor8,9. This
suggests a similar role for G-rich motifs near the 5¢ splice-site
upstream of cassette exons.
This set of predicted alternative splicing motifs is in agreement
with existing studies, including tissue-specific roles for UGUGU,
UCUUUC, UGCAUG, UGUGUC and UUUUU18,25–29. In other
cases, motifs identified in the literature, such
as ACUAAC29,30, lie just below our threshold
of statistical significance. Fagnani et al.17 iden-
tified pyrimidine-rich intronic motifs adjacent
to brain-enriched cassette exons but with
enrichment spread over several genomic
regions and with other motifs, such as
UGCAUG, scoring lower.
High-resolution map of RNA alternative-
splicing regulation
We expected motif enrichment to occur non-
uniformly across the neighborhoods, espe-
cially within the 200-nucleotide intronic
regions. To more precisely predict where indi-
vidual motifs exert a regulatory impact, we
examined each motif ’s frequency at each
nucleotide position in each of the eight neigh-
borhoods, using a Gaussian wavelet for
smoothing (Methods).
UGCAUG occurs 10–80 nucleotides
following muscle cassette exons
The motif UGCAUG has been associated with
Fox proteins6. We found UGCAUG enrich-
ment highest in the intronic neighborhood
following cassette exons upregulated in
striated muscle (Fig. 4c). When examined at
higher resolution, the regulatory influence of
UGCAUG in muscle varied across and within
the eight neighborhoods (Fig. 7). A broad,
highly significant enrichment of UGCAUG
occurred from 10 to 80 nucleotides down-
stream of cassette exons upregulated in heart
and skeletal muscle. A second enrichment
peak occurred from 65 to 15 nucleotides
preceding cassette exons downregulated in
heart, whereas less enrichment occurred in
skeletal muscle in this region. Using RT-PCR, RNAi and cDNA
overexpression, we validated the position-specific influence of
UGCAUG on cassette exon inclusion, identified Fox alternative-
splicing targets and found that the targets are enriched for genes
involved in neuromuscular function31.
UCUCU occurs 110–35 nucleotides preceding regulated
cassette exons
UCUCU has been associated with PTB proteins3–5. The motif
UCUCU frequently occurs directly upstream of 3¢ splice sites as part
of the polypyrimidine tract. Indeed, when we examined constitutive
and cassette exons, both showed high UCUCU occurrence at the 3¢
splice site relative to the average intronic rate. However, enrichment
upstream of constitutive exons extended only 35 nucleotides from the
3¢ splice site into the upstream intron, whereas tissue-varying cassette
exons showed extended enrichment (Fig. 8a). Exons upregulated
in cerebellum showed marked UCUCU enrichment from –95 to
–15 nucleotides (Fig. 8a). Fetal kidney showed UCUCU enrichment
in a similar location, from –75 to –20 nucleotides, although this
enrichment surrounded downregulated cassette exons. Almost every
tissue showed UCUCU enrichment in a similar location, from –110 to
–35 nucleotides preceding cassette exons (Fig. 8b). To our knowledge,
this is the first high-resolution map of UCUCU location and splice
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regulatory influence. Brain tissues, spinal cord, retina and striated
muscle showed enrichment preceding upregulated cassette exons,
whereas other samples showed enrichment preceding downregulated
cassette exons. Thus, we find that UCUCU enrichment occurs in the
polypyrimidine tract immediately preceding the 3¢ splice site upstream
of all exons, but enrichment from –110 to –35 nucleotides occurs only
upstream of tissue-regulated cassette exons.
Exonic splicing elements act to define exons (see ref. 32–34 for
examples). Although we examined both introns and exons for motifs
associated with tissue-varying cassette exons, only intronic motifs
passed the P-value cutoff. This might suggest that intronic motifs
have a greater role in tissue-specific cassette exon regulation, but we
searched only 39 nucleotides of each exonic region compared to 200
nucleotides for each intronic region, and the smaller window lessens
the computed significance of exonic motifs. Indeed, we see evidence for
exonic UCUCU enrichment at the 3¢ edge of cassette exons expressed at
higher levels in brain and heart but at less significant P values (Fig. 8b).
We also did not build cross-species conservation into our statistical
model for motif detection. To assess whether more complex motif-
detection methods would significantly alter our results, we tested
several other published methods, both pre-filtering sequences using
cross-species conservation (for example, ref. 35), and filtering
motifs based on frequency in neighbor-
hoods adjacent to alternate and constitutive
exons (for example, ref. 36). The results were
largely similar in terms of the motifs identified,
associated samples and associated locations
(Supplementary Note). For example, the
P value for UGCUAG enrichment downstream
of skeletal muscle enriched exons changed
from 1  10–16 to 1  10–12 when using
conservation and is still the most significant
word. The next enriched word in both cases is
the related word GCAUGU at 1  10–9 and
1  10–7, respectively. Exonic motifs remain
below significance.
UGCU, UGUGU and AG-rich motifs show
different localization
Other previously established relationships
between RNA-binding proteins and motifs
include muscleblind proteins binding
UGCU10, and CELF12 and SUP-12
(RBM38)12,13 proteins interacting with
UGUGU. Here UGCU enrichment occurs
upstream of cassette exons upregulated in
brain, from –100 to –5 nucleotides upstream
of the 3¢ splice site. Less significant enrich-
ment is found 5–50 nucleotides downstream
of brain-upregulated cassette exons. Skeletal
muscle and heart show enrichment 30–110
nucleotides following upregulated cassette
exons but not upstream. UGUGU shows
consistent enrichment 10–100 nucleotides fol-
lowing brain and spinal cord upregulated
cassettes. hnRNP A/B and hnRNP F/H bind
purine-rich motifs GGGG and AGGGG,
respectively8,9. In our data, AGGG and similar
purine motifs are depleted preceding brain
upregulated cassette exons (Fig. 5). When
examined at higher resolution, depletion of
AG-rich motifs occurs over a wide region. In cerebellum, the depletion
ranges from 150 nucleotides preceding the cassette exon to over 100
nucleotides beyond the exon.
FOX and PTB act on nonoverlapping sets of cassette exons
As both the UCUCU and UGCAUG words seem to regulate alternative
splicing in some of the same samples, but only when positioned in
precise regions around exons, we explored whether they occur around
the same cassette exons. In cassette exons upregulated in skeletal
muscle, we counted occurrences of UCUCU in the region –110 to
–35 nucleotides upstream of the cassette exon and UGCAUG in the
region from 10 to 80 nucleotides downstream of the cassette exon
(Supplementary Fig. 3 online). At least one of the motifs occurs
adjacent to 33% of cassette exons upregulated in skeletal muscle.
However, they co-occur adjacent to only 2% of the exons, not
significantly below the 3% expected by chance (P ¼ 0.2), suggesting
these two motifs, both enriched in muscle, represent independent
regulatory mechanisms. In cerebellum, as in skeletal muscle,
UGCAUG and UCUCU are both associated with upregulated cassette
exons. We found that 10% and 23% of the cassette exons upregulated
in cerebellum contain the motif in the identified region, respectively,
and 31% of the exons contain at least one motif. The motifs co-occur
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Figure 6 Motif enrichment downstream of cassette exons upregulated in human tissues and cell lines.
Values (–log10 e value) are positive for enrichment and negative for depletion. Motifs and tissues are
clustered using agglomerative clustering.
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adjacent only 2% of the exons, the percentage expected by chance,
suggesting independent action as in skeletal muscle. In fetal kidney, on
the other hand, UGCUAG is not enriched adjacent to up- or down-
regulated cassette exons, likely reflecting the lower levels of Fox-1
expression, whereas UCUCU enrichment occurs upstream of down-
regulated cassette exons, likely reflecting
higher levels of PTB expression.
Predicted relationships of RNA-binding
proteins and motifs
The large number of samples and splicing
events in the compendium can be leveraged
to predict associations between trans-acting
splicing regulatory proteins and binding
elements. For 135 of the motifs identified
(Figs. 5 and 6), we calculated a signed,
normalized rank-order metric representing
the similarity between the motif enrichment
or depletion (P value) tissue profiles and
the gene expression profiles of RNA-binding
proteins (Supplementary Figs. 4 and 5
online and Methods). The results of this
calculation represent de novo predictions
of potential protein-motif partners and
capture many known relationships. PTBP1
has the highest absolute score, with a negative
value for UCUCU upstream of cassette
exons and a negative association also with
pyrimidine-rich motifs downstream of
upregulated cassette exons, as previously
established4,37. Upstream of upregulated
exons, UCUCU is enriched when PTBP1
expression is low but not when it is high.
Upstream of downregulated exons, UCUCU
is more often enriched when PTBP1 is
expressed. Thus, cassette exons preceded
by UCUCU are downregulated when PTBP1
is expressed and upregulated when PTBP1
is absent. Upstream of cassette exons,
HNRPF has the highest positive score
for the purine motif AGGG, and HNRPF
and HNRPH1 are known to interact
with AG-rich and G-motifs8,9. Downstream
of cassette exons, the CELF protein CUGBP2
ranks highest for exon inclusion using
UGUGUG, and Fox proteins A2BP1 and
RBM9 rank first and second, respectively, for UGCAUG. SFRS6,
SFRS7 and HNRPF score positively for AGGG. The fact that
expression of Fox, CELF and HNRPF are positively associated
with their motifs surrounding upregulated cassette exons implies
that the exons are preferentially included when the protein is
a
b
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Figure 7 Higher-resolution enrichment of UGCAUG adjacent heart-regulated cassette exons. Middle:
smoothed fraction of the cassette exons with UGCAUG. Red, heart upregulated cassette exons;
blue, heart downregulated; green, all monitored exons; filled gray regions, RefSeq exons. Bottom:
hypergeometric probability (–log10 P value) for up- and downregulated exons relative to all
monitored exons.
Figure 8 Higher-resolution enrichment of UCUCU
adjacent regulated cassette exons. (a) Smoothed
fraction of the cassette exons with UGCAUG in
cerebellum (upper) and fetal kidney (lower). Red,
upregulated cassette exons; blue, downregulated;
green, all monitored exons; filled gray regions,
RefSeq exons. Maximum significance in cere-
bellum/uif is P value o1  10–22; maximum
proportion is 52. Colors are as in Figure 7
(b) Hypergeometric probability (–log10 P value)
for up- and downregulated exons relative to all
monitored exons. At each point, the most
significant P value associated with either up- or
downregulated exons is shown. Samples are
ordered alphabetically as in Figure 2.
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expressed, and suggests a mechanism where the protein acts to
enhance inclusion of exons that are otherwise skipped.
The RNA-binding protein NOVA1 targets YCATYand YCAY motifs,
with a position-dependent influence38,39. We examined our data for
this degenerate motif, summing the values for all four words of
YCATY (CCATC, CCATT, TCATC, TCATT) and calculating the
hypergeometric probability against the count of the similar set of
words in the background. Exons downregulated in brain are enriched
in YCATY upstream, whereas exons upregulated in brain are depleted
of YCATY upstream and enriched downstream (Supplementary Fig. 6
online). We observed NOVA1 levels almost tenfold higher than the
pool in brain and spinal cord, corroborating a regulatory mechanism
in which NOVA1 expression causes exon skipping when bound to
upstream YCATY and exon inclusion when bound to YCATY down-
stream of the exon. These results are fully consistent with previous
reports on the position-specific role of NOVA1 (ref. 39).
DISCUSSION
This is the first genome-scale compendium of human alternative
splicing events and the largest alternative splicing–event compendium
of any species, with each isoform of 24,426 splicing events measured in
48 tissues and cell lines. These data provide a resource for further
studies of the expression and regulation of the transcriptome with
detail not available previously. We also provide a catalog of annotated
splicing events; the mapping of all probes to the hg18 human genome,
viewable in the UCSC browser; and the expression of each probe,
gene, exon, splicing event and all word enrichments in each tissue.
Although not investigated here, these data will be of substantial value
in mapping and analyzing alternative 5¢ and 3¢ exon usage and tissue-
specific alternative polyadenylation.
The splicing event expression compendium was then used to
identify candidate regulatory motifs, identifying 143 motifs in five
main groups that are associated with tissue-varying alternative spli-
cing. For each motif, we measured the enrichment in each tissue and
neighborhood combination and determined the regulatory impact
(inclusion or exclusion) on the associated cassette exon. In cerebellum,
for example, over 30% of the preferentially included cassette exons are
adjacent to either a PTB (–110 to –35 nucleotides upstream) or Fox
(10 to 80 nucleotides downstream) motif.
Our results extend previous studies of motifs in brain and muscle to
48 diverse samples, and present tissue- and position-specific maps of
each motif ’s likely regulatory influence at a resolution that to
our knowledge is only currently available for YCAY (Nova)39.
With the more precise location of motif regulatory impact, we are
able to show that co-occurrence rate of the UGCAUG (Fox)
and UCUCU (PTB) motifs around tissue-regulated cassette exons
is similar to that expected by chance, suggesting that they
act independently.
Finally, we used splicing array data to identify RNA regulatory
motifs and predict binding elements for RNA-binding proteins
de novo. Although these predictions will require further validation,
the fact that many established associations rank highly (for example,
UGCAUG with Fox-1, UCUCU with PTB1 and UGUGUG with
CELF) suggests that these results could be used as part of a prioritiza-
tion scheme for further experimentation.
METHODS
Microarray pattern generation. We downloaded genome and transcript
sequences from the National Center for Biotechnology Information on January
8, 2003. We aligned RefSeq, mRNA, EST40 and patent transcripts to the genome
using sim4 (ref. 41) and identified all exons and exon–exon junctions. We also
aligned mouse transcripts to the human genome to identify possible splice
forms not yet present in human transcript databases42. An optimized
60-nucleotide probe was designed to monitor each exon and a 36-nucleotide
probe was centered across each exon–exon junction43. Exons less than
60 nucleotides were monitored using shorter probes attached to T-stilts. Probes
predicted to perform poorly, such as those associated with repeat sequences or
containing unacceptable GC content, were discarded. In total, 383,014 oligo-
nucleotide probes to monitor 203,672 exons and 178,351 exon–exon junctions
in 17,939 genes were synthesized to a 17 array set, with each array containing
23,107 noncontrol probes. Arrays were ordered from Agilent. Probes have been
mapped to the hg18 genome and can be viewed with the UCSC genome
browser using the supplementary probe alignment file (see URLs section
below).
Tissue preparation and hybridization. We hybridized 48 diverse human
tissues and cell lines to this array set. Samples were purchased as pools from
multiple donors, typically over ten (Clontech). We isolated poly(A)+ RNA
from each sample, amplified and labeled the entire transcript structure with
Cy3 and Cy5 (ref. 43) and hybridized all samples against a common reference
pool in a dye-swamp replicate experiment44. Pooled RNA from 20 diverse
disease-free adult tissue pools comprised the reference pool. Single array
intensities were normalized spatially and for overall intensity; fluor-reverse
pairs were combined; and intensity, relative change (log10 ratio) and uncer-
tainty values were output for each probe and sample45. Tissue-specific probe
intensities were further normalized by the pool intensity for the specific probe,
relative to the average intensity of the pool for the probe when hybridized
against other samples.
Gene expression. We determined gene expression by averaging values from
three selected probes per gene. Probes were prioritized by location in con-
stitutively transcribed exons or junctions and then by correlation with the
average of all constitutive-element-monitoring probes across the 48 samples.
From the three probes, log10 expression ratios represent the error-weighted
average ratio to the pool and intensities as the average probe intensity. P values
are assigned to relative expression values using the uncertainty and reflect the
probability of no differential expression between the sample and the pool.
Alternative splicing event profiling. We identified putative mutually exclusive
alternative splicing events found in our alignment of RefSeq, GenBank, dbEST,
patent and mouse transcripts to the human build 35 version 1 genome
assembly46. As per the microarray design process, transcripts were aligned to
the genome, and exon and exon–exon junction coordinates were identified. For
each gene, we examined the exon and junction coordinates for mutually
exclusive splicing events, including cassette exons (single and multiple),
mutually exclusive exons, alternative 5¢ and 3¢ splice sites, and retained introns.
The exon and junction nucleotide sequence specific to each form was extracted;
probes were associated with each form on the basis of sequence identity.
For alternative splicing events for which both inclusion and exclusion were
monitored, we calculated a relative change (log10 ratio) to the reference pool
and intensity for each form. If multiple probes reported on a form, we
combined log10 ratios using error-weighted averaging and calculated a median
intensity. To estimate the proportion of a given splice form relative to the pool,
we used ‘‘method 1 + 2’’ of Ule et al.14, similar to a method described by
Fehlbaum et al.47. For a given alternative splicing event, log ratios monitoring
event inclusion and exclusion were normalized by gene expression to isolate
splicing changes from transcription changes. We then compared these normal-
ized inclusion and exclusion log ratios. The output is a measure of the change
in percentage of one splice form, such that a change from 80% of total to 20%
of total is reported as –60. If no change in alternative splicing occurs, the
method is unable to assign proportionality.
Error estimate and significance calls for differential splice expression. We
added an uncertainty, P value and filtering to the alternative splicing–event
profiling. We flagged events for which the gene intensities were below the noise
level in either sample, for which the event intensities were below the noise level
in both samples, or for which either the gene or event intensities were near
saturation levels in either sample. We also flagged events showing intensity
more than tenfold higher than the gene intensity, as this represents possible
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cross-hybridization. In true cases of differential alternative splicing, the log10
ratios monitoring the splice event inclusion and exclusion should have opposite
signals after removal of the gene expression changes; we therefore flagged those
not consistent. Using standard error propagation48, we calculated an uncer-
tainty with each log ratio measurement and a P value for each splicing event,
representing the probability that the splicing event is not differentially
expressed after accounting for gene expression changes. We considered splice
events with a change of at least magnitude 5, a P value less than 0.3 and no flags
as significantly differentially expressed.
Validation of splicing event profiling. In conjunction with the Cooper
laboratory (Baylor), we established validation rates for this platform. We
profiled mouse heart at different development stages (T.A.C., unpublished
data). We tested 23 microarray predictions (with P valueo0.1 and passing the
intensity and cross-hybridization filters described above) and found that 17
(74%) showed RT-PCR–determined proportionality changes exceeding 15
percentage points (for example, isoform A changes from 60% to 45% of the
total) and the correlation between microarray and RT-PCR splice event profiles
was r ¼ 0.88 (Supplementary Table 1).
Re-ratio of microarray data. The microarray values were derived from two-
color hybridizations of the sample and a common reference pool. For each
sample, the resultant values included an intensity, log10 ratio to pool, and log10
ratio-to-pool uncertainty. To define a different pool in silico using one of the
existing samples, the log10 ratio to ‘new pool’ was calculated for each sample as
the difference between the log10 ratio to pools from the sample and from the
new pool sample. The log10 ratio to ‘new pool’ uncertainty was calculated as the
square root of the sum of the squares of each log10 ratio-to-pool uncertainty.
Motif identification. For each tissue, we identified up- and downregulated
cassette exons and searched associated genomic regions for over- and under-
represented motifs. Up- and downregulated cassette exons were identified that
passed the described intensity and consistency filters and showed a minimum
percent inclusion change of 5 and a P value lower than 0.3. For each cassette
exon, we extracted the repeat-masked nucleotide sequence in eight regions,
including the 3¢ edge of the previous exon, the intronic region adjacent the
upstream 5¢ splice site, the intronic region adjacent the upstream 3¢ splice site,
the 5¢ region of the cassette exon, the 3¢ region of the cassette exon, the intronic
region adjacent the downstream 5¢ splice site, the intronic region adjacent the
downstream 3¢ splice site and the 5¢ edge of the following exon. For intronic
and exonic regions, we extracted 200 nucleotides and 39 nucleotides, respec-
tively, based on previous studies18,39,49 and required introns to be at least 300
nucleotides to limit the impact of neighboring splice sites.
The neighborhood-specific background set included sequences from the set
of cassette exons monitored on the microarrays. For each neighborhood in each
tissue, we counted the occurrence of every word, size 3 through 7. Then, for
each word, tissue and region, we used the cumulative hypergeometric distribu-
tion to assign a P value representing the probability for observing that number
of occurrences in the foreground versus the number in the background set. In
cases where we examined enrichment (inverse cumulative hypergeometric) and
depletion (cumulative hypergeometric), the most significant P value was
retained and a sign, positive or negative, was assigned to the P value depending
on whether enrichment or depletion, respectively, was most significant.
Counting the number of motifs, rather than the number of cassette exons
with the motif, was more sensitive for motifs that commonly occur in a given
region, such as UCUCU upstream of cassette exons.
To identify motifs, such as those in plotted Figure 5, we identified words
with signed hypergeometric P values more significant than 1  10–3 (Bonfer-
roni corrected) in any tissue in the specific neighborhood, minus words found
in longer words with more significant P values. Using randomized exon
annotations, we calculated a false-discovery rate (FDR) for each motif in each
neighborhood. UUUUU and AAAAA had significantly higher FDRs and were
excluded from further analysis.
For the high-resolution enrichment study, the number of motifs at each
position was convolved with a Gaussian wavelet. The Gaussian wavelet was
width 40, with maximum value of 1 at position zero, falling to 0.26 at ± 20. The
smoothed counts were calculated at each position for tissue-upregulated
cassette exons, tissue-downregulated cassette exons and the background sets.
We again used the hypergeometric distribution to calculate P values for
enrichment and depletion from the smoothed motif counts, in both tissue-
upregulated and tissue-downregulated sets, versus the corresponding motif
counts from the set of all cassette exons monitored.
Co-regulation of motifs and RNA-binding protein transcript expression. We
considered RNA-binding proteins found in the Panther mRNA splicing gene
set and those classified by Interpro as having a RNP domain. Muscleblind
proteins (for example, MBNL2) are not included in these sets; they are found in
24 genes in the Panther double-stranded DNA binding set, so we included this
set as well. For each significant motif in each genomic region, we calculated a
nonparametric score by sorting tissue enrichment rankings on the basis of the
gene expression rankings for each protein and identifying the greatest diver-
gence from random. The maximum value for each motif was normalized to 1.
We preserved the sign to represent positive and negative divergence. Clustering
in figures is agglomerative clustering.
URLs. Compendium of alternative splicing expression, gene expression, probe
and splicing event nucleotide sequences, genome browser tracks, and individual
splicing event figures: http://rulai.cshl.edu/Rosetta_AS_supp/ and http://
rulai.cshl.edu/dbCASE.
Accession codes. NCBI GEO: microarray data have been deposited with
accession code GSE11863. GenBank: CLK1, NM_004071; CLK2, NM_003993;
A2BP1, NM_018723 and NM_145893.
Note: Supplementary information is available on the Nature Genetics website.
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